GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Akdital (CAS:AKT) » Definitions » Buyback Yield %

Akdital (CAS:AKT) Buyback Yield % : 0.00 (As of Jun. 13, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Akdital Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Akdital's current buyback yield was 0.00%.


Akdital Buyback Yield % Historical Data

The historical data trend for Akdital's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akdital Buyback Yield % Chart

Akdital Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Buyback Yield %
- - - -21.99

Akdital Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Buyback Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Akdital's Buyback Yield %

For the Medical Care Facilities subindustry, Akdital's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akdital's Buyback Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Akdital's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Akdital's Buyback Yield % falls into.



Akdital Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Akdital's Buyback Yield for the fiscal year that ended in Dec. 2022 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 768.9) / 3496.0092
=-21.99%

Akdital's annualized Buyback Yield for the quarter that ended in Jun. 2023 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 2 / 4401.67825
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Jun. 2023) data.


Akdital Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Akdital's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Akdital (CAS:AKT) Business Description

Traded in Other Exchanges
N/A
Address
258 Route de l’Oasis, Casablanca, MAR, 20250
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, neurosurgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.

Akdital (CAS:AKT) Headlines

From GuruFocus

Xchange Benefits Launches Xchange Re Underwriting Agency, LLC

By Business Wire Business Wire 01-17-2023

Ambac to Release Third Quarter 2022 Results on November 8, 2022

By Business Wire Business Wire 10-25-2022

Ambac to Release Fourth Quarter 2022 Results on February 28, 2023

By Business Wire Business Wire 02-14-2023

Ambac Reports Second Quarter 2023 Results

By Business Wire 08-07-2023

Ambac Settles RMBS Litigation Against Nomura

By Business Wire Business Wire 01-03-2023

Ambac Releases Statement Regarding Speculative Acquisition Report

By Business Wire Business Wire 12-08-2022

Ambac to Release Second Quarter 2022 Results on August 8, 2022

By Business Wire Business Wire 07-26-2022